WHO ICTRP trial
Evaluation of the efficacy, safety and injection interval of intravitreal…
JPRN-UMIN000012038 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000012038 |
|---|---|
| Public title | Evaluation of the efficacy, safety and injection interval of intravitreal injection of ranibizumab for retinal vein occlusion |
| Scientific title | Evaluation of the efficacy, safety and injection interval of intravitreal injection of ranibizumab for retinal vein occlusion - intravitreal injection of ranibizumab for retinal vein occlusion |
| Primary sponsor | Department of Ophthalmology, Shiga University of Medical Science |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | retinal vein occlusion |
| Interventions | Duration:12 months Quantity: ranibizumab 0.5 mg Bimonthly injection |
| Registration date | Oct 15, 2013 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: